MDPHP is assumed to act generally like a potent norepinephrine-dopamine reuptake inhibitor (NDRI). Minimized re-uptake of norepinephrine and dopamine leads to greater concentrations of The 2 catecholamine neurotransmitters while in the synaptic cleft, or gap in between neurons. The results of this inhibition is undoubtedly an enhanced and prolonged concentration https://cashbcccb.blogocial.com/new-step-by-step-map-for-monkey-dust-drug-67134749